[go: up one dir, main page]

AU5089400A - Arthritis treatment - Google Patents

Arthritis treatment

Info

Publication number
AU5089400A
AU5089400A AU50894/00A AU5089400A AU5089400A AU 5089400 A AU5089400 A AU 5089400A AU 50894/00 A AU50894/00 A AU 50894/00A AU 5089400 A AU5089400 A AU 5089400A AU 5089400 A AU5089400 A AU 5089400A
Authority
AU
Australia
Prior art keywords
arthritis treatment
arthritis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50894/00A
Inventor
Clair Adcocks
David Buttle
Peter Collin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0007321A external-priority patent/GB0007321D0/en
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of AU5089400A publication Critical patent/AU5089400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU50894/00A 1999-06-07 2000-06-06 Arthritis treatment Abandoned AU5089400A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13769999P 1999-06-07 1999-06-07
US60137699 1999-06-07
GB0007321 2000-03-27
GB0007321A GB0007321D0 (en) 2000-03-27 2000-03-27 Arthritis treatment
PCT/GB2000/002048 WO2000074662A2 (en) 1999-06-07 2000-06-06 Arthritis treatment

Publications (1)

Publication Number Publication Date
AU5089400A true AU5089400A (en) 2000-12-28

Family

ID=26243965

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50894/00A Abandoned AU5089400A (en) 1999-06-07 2000-06-06 Arthritis treatment

Country Status (4)

Country Link
EP (1) EP1207862A2 (en)
JP (1) JP2003501381A (en)
AU (1) AU5089400A (en)
WO (1) WO2000074662A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020146472A1 (en) 2000-11-15 2002-10-10 Chen Kuang Yu Black tea extract for prevention of disease
WO2002069883A2 (en) * 2001-02-06 2002-09-12 Universita Degli Studi Di Padova Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders
JP2004535434A (en) * 2001-06-25 2004-11-25 デピユイ Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
CA2451248A1 (en) * 2001-06-25 2003-01-03 Depuy International Limited Composition comprising glycosaminoglycans and hyaluronidase inhibitors for the treatment of arthritic joints
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
KR100621234B1 (en) 2002-04-30 2006-09-13 유니젠 파아마슈티컬스,인크. Formulation of a Mixture of Free-B-Ring Flavonoids and Flavans as a Therapeutic Agent
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
JP4769184B2 (en) 2003-04-04 2011-09-07 ユニジェン・インコーポレーテッド Formulation of cyclooxygenase (COX) and lipoxygenase (LOX) dual inhibitors for mammalian skin care
WO2004091642A1 (en) * 2003-04-11 2004-10-28 Kyowa Hakko Kogyo Co. Ltd. Preventive or remedy for arthritis
US7858080B2 (en) 2005-05-20 2010-12-28 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
WO2006124000A1 (en) * 2005-05-20 2006-11-23 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
JP2008542300A (en) * 2005-05-24 2008-11-27 ウェルルゲン インコーポレーテッド Compositions and methods for preventing and treating conditions associated with inflammation
DE102005029845B4 (en) 2005-06-27 2017-03-23 Orgentec Diagnostika Gmbh Method for the diagnosis of rheumatic diseases
AU2006308596A1 (en) * 2005-11-01 2007-05-10 Mars, Incorporated Flavanols and B-type procyanidins and inflammation
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
WO2014184246A1 (en) * 2013-05-14 2014-11-20 Mars, Incorporated Joint care composition
US10716959B2 (en) * 2013-09-03 2020-07-21 Agency For Science, Technology And Research Polymer-flavonoid conjugates and hydrogels for biomedical applications
JP6242669B2 (en) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 Hyaluronic acid production promoter containing a sarnashi extract
WO2015171079A1 (en) * 2014-05-09 2015-11-12 Agency For Science, Technology And Research A micellar nanocomplex
WO2015174934A1 (en) * 2014-05-15 2015-11-19 Agency For Science, Technology And Research Polymer-flavonoid conjugate and uses thereof
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
JP6742575B2 (en) * 2015-07-02 2020-08-19 株式会社東洋新薬 Joint function improving composition
JP2018100238A (en) * 2016-12-21 2018-06-28 花王株式会社 Ambulatory function improver
IT202200013867A1 (en) * 2022-06-30 2023-12-30 Lo Li Pharma Srl COMPOSITION FOR THE TREATMENT OF PAPILLOMA VIRUS (HPV) INFECTION
WO2025219934A1 (en) * 2024-04-18 2025-10-23 The Wave Innovation Group S.R.L. Composition based on hyaluronic acid, epigallocatechin-3-o- gallate and/or xanthohumol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268517A (en) * 1979-08-30 1981-05-19 Continental Pharma Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
BE886568A (en) * 1980-12-09 1981-06-09 Continental Pharma PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DEGENERATIVE CONDITIONS OF ARTICULAR CARTILAGE, AND METHOD OF USE THEREOF.
JPH07223941A (en) * 1994-02-14 1995-08-22 Nippon Ham Kk Anticomplementary substance
IT1275905B1 (en) * 1995-03-14 1997-10-24 Indena Spa POLYPHENOLIC FRACTIONS OF TEA, THEIR USE AND FORMULATIONS THAT CONTAIN THEM
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
JP3718543B2 (en) * 1995-06-28 2005-11-24 天野エンザイム株式会社 Process for producing glycosides and glycosyl transfer products
GB2306321A (en) * 1995-10-24 1997-05-07 Anne Child The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders
JPH09227374A (en) * 1996-02-28 1997-09-02 Taiyo Kagaku Co Ltd Stress protein production suppressing composition
JP4507027B2 (en) * 1998-12-04 2010-07-21 明治乳業株式会社 MMP inhibitor
SE9900473D0 (en) * 1999-02-12 1999-02-12 Karolinska Innovations Ab Inhibitor of endothelial cell proliferation

Also Published As

Publication number Publication date
WO2000074662A3 (en) 2002-03-14
WO2000074662A2 (en) 2000-12-14
EP1207862A2 (en) 2002-05-29
JP2003501381A (en) 2003-01-14

Similar Documents

Publication Publication Date Title
AU5089400A (en) Arthritis treatment
AU2020501A (en) Chemotherapy treatment
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5547000A (en) Novel treatment
AU1772399A (en) Well treatment
AU1538901A (en) Polymersation process
AU7514700A (en) Cyanopiperidines
AU4115400A (en) Short-circuiter
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU2699800A (en) Organoceramics
AU4556800A (en) Novel treatment
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU4434600A (en) Reducer
AU1901801A (en) Glucofuranoses
AU4435300A (en) Hula-hoop
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU2197301A (en) Microlamp
AU5524399A (en) Inorgasmia treatment
AU1737601A (en) Collectalbum
GB9912313D0 (en) Arthritis treatment
AU5675000A (en) Process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase